Framework Journal · one stock, one dated entry

Recorded 2026-06-14 · Permanent

Amplify Seymour Cannabis ETF CNBS

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

In plain words · Under normal market conditions, the fund seeks to achieve its investment objective by investing in the securities of U.S.

The label
Markdown

read at $30.71

Amplify Seymour Cannabis ETF holds its Markdown at $30.71.

PHINPOOPSC
  • PHPhase · the trend structure carries the Markdown label
  • INInsiders · no filings inside 60 days, left as found
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · does not pass the values gate
  • edge confirmed
  • edge broken
  • edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2026-06-14
PhaseMarkdown · caution
Quantitative stateElevated stress, defensive posture warranted, held for 26 days
Price$30.71
Valuation21.92 trailing · N/A forward price to earnings
Values screenFAIL · score 30.0
BetaN/A

The business, in plain words · what the numbers mean

The fundamentals · plain-English read
Trailing P/E21.9x
a premium valuation

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

The trader read · the latest dated commentary

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 30%. Entered 2026-07-25 · Markdown

The dated journal · newest first, never edited

2026-07-25 Markdown $30.71 +0.0% Entry 4

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 30%.

2026-07-18 Markdown $30.71 +0.0% Entry 3

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 110%. Our forward projection puts the odds of a 10% gain over the next month near 30%.

2026-07-03 Markdown $30.71 +0.0% Entry 2

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Markdown $30.71 Entry 1

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $29.11 +8.4% · $1,084 +8.4%
2 months $22.92 +37.7% · $1,377 +37.7%
3 months $22.97 +37.4% · $1,374 +37.4%
6 months $22.53 +40.1% · $1,401 +40.1%
1 year $15.01 +110.3% · $2,103 +110.3%
2 years $38.79 -18.6% $10.72 $1,090 +9.0%
3 years $30.52 +3.4% $10.72 $1,385 +38.5%
5 years $215.97 -85.4% $10.72 $196 -80.4%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever CNBS does next, these words stay.

Amplify Seymour Cannabis ETF · CNBS · Markdown · $30.71
Recorded 2026-06-14 · before the outcome · scored mechanically

Get our weekly market brief free.